{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T20:13:29Z","timestamp":1782159209107,"version":"3.54.5"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T00:00:00Z","timestamp":1736640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T00:00:00Z","timestamp":1736640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["72274045"],"award-info":[{"award-number":["72274045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"DOI":"10.1186\/s12955-025-02332-8","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T23:31:58Z","timestamp":1736638318000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Health utility scores of six common cancers in China measured by SF-6Dv2"],"prefix":"10.1186","volume":"23","author":[{"given":"Yuchun","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8156-5537","authenticated-orcid":false,"given":"Yiyin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8673-0933","authenticated-orcid":false,"given":"Hongbin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7168-0128","authenticated-orcid":false,"given":"Tiemin","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6107-5305","authenticated-orcid":false,"given":"Weidong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,12]]},"reference":[{"issue":"7","key":"2332_CR1","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/cm9.0000000000001474","volume":"134","author":"W Cao","year":"2021","unstructured":"Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021;134(7):783\u201391. https:\/\/doi.org\/10.1097\/cm9.0000000000001474.","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"2332_CR2","doi-asserted-by":"publisher","first-page":"879","DOI":"10.20892\/j.issn.2095-3941.2020.0387","volume":"17","author":"D Sun","year":"2020","unstructured":"Sun D, Li H, Cao M, He S, Lei L, Peng J, Chen W. Cancer burden in China: trends, risk factors and prevention. Cancer Biol Med. 2020;17(4):879\u201395. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2020.0387.","journal-title":"Cancer Biol Med"},{"issue":"5","key":"2332_CR3","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/s2214-109x(18)30127-x","volume":"6","author":"H Zeng","year":"2018","unstructured":"Zeng H, Chen W, Zheng R, Zhang S, Ji JS, Zou X, Xia C, Sun K, Yang Z, Li H, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018;6(5):e555\u201367. https:\/\/doi.org\/10.1016\/s2214-109x(18)30127-x.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"2332_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3760\/cma.j.cn112152-20240119-00035","volume":"46","author":"RS Zheng","year":"2024","unstructured":"Zheng RS, Chen R, Han BF, Wang SM, Li L, Sun KX, Zeng HM, Wei WW, He J. [Cancer incidence and mortality in China, 2022]. Zhonghua Zhong Liu Za Zhi. 2024;46(3):221\u201331. https:\/\/doi.org\/10.3760\/cma.j.cn112152-20240119-00035.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"11","key":"2332_CR5","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1007\/s11427-022-2240-6","volume":"66","author":"Y Wang","year":"2023","unstructured":"Wang Y, Yan Q, Fan C, Mo Y, Wang Y, Li X, Liao Q, Guo C, Li G, Zeng Z, et al. Overview and countermeasures of cancer burden in China. Sci China Life Sci. 2023;66(11):2515\u201326. https:\/\/doi.org\/10.1007\/s11427-022-2240-6.","journal-title":"Sci China Life Sci"},{"issue":"2","key":"2332_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.healthpol.2018.11.003","volume":"123","author":"L Maynou","year":"2019","unstructured":"Maynou L, Cairns J. What is driving HTA decision-making? Evidence from cancer drug reimbursement decisions from 6 European countries. Health Policy. 2019;123(2):130\u20139. https:\/\/doi.org\/10.1016\/j.healthpol.2018.11.003.","journal-title":"Health Policy"},{"issue":"3","key":"2332_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s40258-020-00634-0","volume":"19","author":"Y Wang","year":"2021","unstructured":"Wang Y, Qiu T, Zhou J, Francois C, Toumi M. Which Criteria are considered and how are they evaluated in Health Technology assessments? A review of methodological guidelines used in Western and Asian countries. Appl Health Econ Health Policy. 2021;19(3):281\u2013304. https:\/\/doi.org\/10.1007\/s40258-020-00634-0.","journal-title":"Appl Health Econ Health Policy"},{"issue":"5","key":"2332_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/14737167.2023.2193877","volume":"23","author":"A Zhang","year":"2023","unstructured":"Zhang A, Mao Z, Wang Z, Wu J, Luo N, Wang P. Comparing measurement properties of EQ-5D and SF-6D in East and South-East Asian populations: a scoping review. Expert Rev Pharmacoecon Outcomes Res. 2023;23(5):449\u201368. https:\/\/doi.org\/10.1080\/14737167.2023.2193877.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"6","key":"2332_CR9","doi-asserted-by":"publisher","first-page":"E34","DOI":"10.1177\/0272989x11421529","volume":"31","author":"DG Whitehurst","year":"2011","unstructured":"Whitehurst DG, Bryan S, Lewis M. Systematic review and empirical comparison of contemporaneous EQ-5D and SF-6D group mean scores. Med Decis Mak. 2011;31(6):E34\u201344. https:\/\/doi.org\/10.1177\/0272989x11421529.","journal-title":"Med Decis Mak"},{"issue":"11","key":"2332_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11136-016-1375-6","volume":"25","author":"F Rencz","year":"2016","unstructured":"Rencz F, Gul\u00e1csi L, Drummond M, Golicki D, P\u00e9ntek M. EQ-5D in Central and Eastern Europe: 2000\u20132015. Qual Life Res. 2016;25(11):1\u201318. https:\/\/doi.org\/10.1007\/s11136-016-1375-6.","journal-title":"Qual Life Res"},{"key":"2332_CR11","unstructured":"Chun-Lin J, Hai-Yin W, Jie C. Methods, applications and recommendations for health technology assessment. Chin Health Resour. 2014."},{"issue":"11","key":"2332_CR12","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/s0895-4356(98)00103-6","volume":"51","author":"J Brazier","year":"1998","unstructured":"Brazier J, Usherwood T, Harper R, Thomas K. Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol. 1998;51(11):1115\u201328. https:\/\/doi.org\/10.1016\/s0895-4356(98)00103-6.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"2332_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/mlr.0000000000001325","volume":"58","author":"JE Brazier","year":"2020","unstructured":"Brazier JE, Mulhern BJ, Bjorner JB, Gandek B, Rowen D, Alonso J, Vilagut G, Ware JE. Developing a New Version of the SF-6D health state classification system from the SF-36v2: SF-6Dv2. Med Care. 2020;58(6):557\u201365. https:\/\/doi.org\/10.1097\/mlr.0000000000001325.","journal-title":"Med Care"},{"issue":"4","key":"2332_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/s0895-4356(02)00609-1","volume":"56","author":"JA Kopec","year":"2003","unstructured":"Kopec JA, Willison KD. A comparative review of four preference-weighted measures of health-related quality of life. J Clin Epidemiol. 2003;56(4):317\u201325. https:\/\/doi.org\/10.1016\/s0895-4356(02)00609-1.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"2332_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11136-013-0503-9","volume":"23","author":"RD Hays","year":"2014","unstructured":"Hays RD, Reeve BB, Smith AW, Clauser SB. Associations of cancer and other chronic medical conditions with SF-6D preference-based scores in Medicare beneficiaries. Qual Life Res. 2014;23(2):385\u201391. https:\/\/doi.org\/10.1007\/s11136-013-0503-9.","journal-title":"Qual Life Res"},{"issue":"5","key":"2332_CR16","doi-asserted-by":"publisher","first-page":"e23556","DOI":"10.5812\/ircmj.23556","volume":"18","author":"M Yousefi","year":"2016","unstructured":"Yousefi M, Najafi S, Ghaffari S, Mahboub-Ahari A, Ghaderi H. Comparison of SF-6D and EQ-5D scores in patients with breast Cancer. Iran Red Crescent Med J. 2016;18(5):e23556. https:\/\/doi.org\/10.5812\/ircmj.23556.","journal-title":"Iran Red Crescent Med J"},{"issue":"2","key":"2332_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s0167-6296(01)00130-8","volume":"21","author":"J Brazier","year":"2002","unstructured":"Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271\u201392. https:\/\/doi.org\/10.1016\/s0167-6296(01)00130-8.","journal-title":"J Health Econ"},{"key":"2332_CR18","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s11136-008-9384-7","volume":"17","author":"PL Ferreira","year":"2008","unstructured":"Ferreira PL, Ferreira LN, Pereira LN. How consistent are health utility values? Qual Life Res. 2008;17:1031\u201342. https:\/\/doi.org\/10.1007\/s11136-008-9384-7.","journal-title":"Qual Life Res"},{"issue":"12","key":"2332_CR19","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/hec.787","volume":"12","author":"L Longworth","year":"2003","unstructured":"Longworth L, Bryan S. An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Econ. 2003;12(12):1061\u20137. https:\/\/doi.org\/10.1002\/hec.787.","journal-title":"Health Econ"},{"key":"2332_CR20","doi-asserted-by":"publisher","first-page":"8404","DOI":"10.34172\/ijhpm.8404","volume":"13","author":"H Ameri","year":"2024","unstructured":"Ameri H, Poder TG. Valuing SF-6Dv2 using a Discrete Choice Experiment in a General Population in Quebec, Canada. Int J Health Policy Manag. 2024;13:8404. https:\/\/doi.org\/10.34172\/ijhpm.8404.","journal-title":"Int J Health Policy Manag"},{"key":"2332_CR21","doi-asserted-by":"publisher","unstructured":"Daroudi R, Zeraati H, Poder TG, Norman R, Olyaeemanesh A, Sari AA, Ameri H. Valuing the SF-6Dv2 in the capital of Iran using a discrete choice experiment with duration. Qual Life Res. 33(7):1853\u201363. https:\/\/doi.org\/10.1007\/s11136-024-03649-5.","DOI":"10.1007\/s11136-024-03649-5"},{"key":"2332_CR22","doi-asserted-by":"publisher","unstructured":"Shiroiwa T, Yamamoto Y, Murata T, Mulhern B, Bjorner J, Brazier J, Fukuda T, Rowen D, Fukuhara SI. Valuation survey for SF-6Dv2 in Japan based on the international protocol. Qual Life Res. https:\/\/doi.org\/10.1007\/s11136-024-03100-.","DOI":"10.1007\/s11136-024-03100-"},{"key":"2332_CR23","doi-asserted-by":"publisher","unstructured":"Mulhern B, Norman R, Brazier J. Valuing SF-6Dv2 in Australia using an international protocol. PharmacoEconomics. 39(10):1151\u201362. https:\/\/doi.org\/10.1007\/s40273-021-01059-0.","DOI":"10.1007\/s40273-021-01059-0"},{"key":"2332_CR24","doi-asserted-by":"publisher","unstructured":"Wu J, Xie S, He X, Chen G, Bai G, Feng D, Hu M, Jiang J, Wang X, Wu H et al. Valuation of SF-6Dv2 health states in China using time trade-off and discrete-choice experiment with a duration dimension. PharmacoEconomics. 39(5):521\u201335. https:\/\/doi.org\/10.1007\/s40273-021-00972-6.","DOI":"10.1007\/s40273-021-00972-6"},{"key":"2332_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-024-01672-4","author":"A Zhang","year":"2024","unstructured":"Zhang A, Li J, Mao Z, Wang Z, Wu J, Luo N, Liu P, Wang P. Psychometric performance of EQ-5D-5L and SF-6Dv2 in patients with lymphoma in China. Eur J Health Econ. 2024. https:\/\/doi.org\/10.1007\/s10198-024-01672-4.","journal-title":"Eur J Health Econ"},{"issue":"7","key":"2332_CR26","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jval.2018.12.012","volume":"22","author":"TG Poder","year":"2019","unstructured":"Poder TG, Fauteux V, He J, Brazier JE. Consistency between three different ways of administering the short form 6 Dimension Version 2. Value Health. 2019;22(7):837\u201342. https:\/\/doi.org\/10.1016\/j.jval.2018.12.012.","journal-title":"Value Health"},{"issue":"5","key":"2332_CR27","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s11136-020-02419-3","volume":"29","author":"J Wu","year":"2020","unstructured":"Wu J, Xie S, He X, Chen G, Brazier JE. The simplified Chinese version of SF-6Dv2: translation, cross-cultural adaptation and preliminary psychometric testing. Qual Life Res. 2020;29(5):1385\u201391. https:\/\/doi.org\/10.1007\/s11136-020-02419-3.","journal-title":"Qual Life Res"},{"issue":"4","key":"2332_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s40258-022-00715-2","volume":"20","author":"S Xie","year":"2022","unstructured":"Xie S, Wu J, Xie F. Population norms for SF-6Dv2 and EQ-5D-5L in China. Appl Health Econ Health Policy. 2022;20(4):573\u201385. https:\/\/doi.org\/10.1007\/s40258-022-00715-2.","journal-title":"Appl Health Econ Health Policy"},{"issue":"4","key":"2332_CR29","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1007\/s00520-020-05729-x","volume":"29","author":"H Ding","year":"2021","unstructured":"Ding H, Mao A, Lin J, Wong MCS, Dong P, Qiu W. Using a Chinese time trade-off approach to explore the health utility level and quality of life of cancer patients in urban China: a multicentre cross-sectional study. Support Care Cancer. 2021;29(4):2215\u201323. https:\/\/doi.org\/10.1007\/s00520-020-05729-x.","journal-title":"Support Care Cancer"},{"issue":"4","key":"2332_CR30","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s12282-021-01230-3","volume":"28","author":"A Nahvijou","year":"2021","unstructured":"Nahvijou A, Safari H, Ameri H. Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population. Breast Cancer. 2021;28(4):937\u201343.","journal-title":"Breast Cancer"},{"key":"2332_CR31","doi-asserted-by":"publisher","unstructured":"Naik H, Howell D, Su S, Qiu X, Brown MC, Vennettilli A, Irwin M, Pat V, Solomon H, Wang T et al: EQ-5D Health Utility Scores: Data from a Comprehensive Canadian Cancer Centre. Patient. 2017, 10(1):105-115. https:\/\/doi.org\/10.1007\/s40271-016-0190-z.","DOI":"10.1007\/s40271-016-0190-z"},{"issue":"6","key":"2332_CR32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.21037\/atm-22-991","volume":"10","author":"YQ Yu","year":"2022","unstructured":"Yu YQ, Ma L, Wang WJ, Zhao YQ, Xu HF, Cao J, Li L, Hao JQ, Gao JR, Gu XF, et al. Health-related quality of life in advanced colorectal cancer patients in China: a nationwide hospital-based survey. Ann Transl Med. 2022;10(6):328. https:\/\/doi.org\/10.21037\/atm-22-991.","journal-title":"Ann Transl Med"},{"issue":"8","key":"2332_CR33","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1089\/thy.2017.0213","volume":"28","author":"T Wang","year":"2018","unstructured":"Wang T, Jiang M, Ren Y, Liu Q, Zhao G, Cao C, Wang H. Health-related quality of life of community thyroid Cancer survivors in Hangzhou, China. Thyroid. 2018;28(8):1013\u201323. https:\/\/doi.org\/10.1089\/thy.2017.0213.","journal-title":"Thyroid"},{"key":"2332_CR34","doi-asserted-by":"publisher","first-page":"767151","DOI":"10.3389\/fpubh.2021.767151","volume":"9","author":"C Zheng","year":"2021","unstructured":"Zheng C, Yu LX, Jia HY, Cui SD, Tian FG, Fan ZM, Geng CZ, Cao XC, Yang ZL, Wang X, et al. Relationship between Lifestyle habits and Health-Related Quality of Life of recently diagnosed breast Cancer patients: a comparison between younger and older women in China. Front Public Health. 2021;9:767151. https:\/\/doi.org\/10.3389\/fpubh.2021.767151.","journal-title":"Front Public Health"},{"key":"2332_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/jgo.2016.008763","volume":"4","author":"J You","year":"2018","unstructured":"You J, Lu Q, Zvolensky MJ, Meng Z, Garcia K, Cohen L. Anxiety- and Health-Related Quality of Life among patients with breast Cancer: a cross-cultural comparison of China and the United States. J Glob Oncol. 2018;4:1\u20139. https:\/\/doi.org\/10.1200\/jgo.2016.008763.","journal-title":"J Glob Oncol"},{"issue":"3","key":"2332_CR36","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s11136-018-2038-6","volume":"28","author":"M Su","year":"2019","unstructured":"Su M, Hua X, Wang J, Yao N, Zhao D, Liu W, Zou Y, Anderson R, Sun X. Health-related quality of life among cancer survivors in rural China. Qual Life Res. 2019;28(3):695\u2013702. https:\/\/doi.org\/10.1007\/s11136-018-2038-6.","journal-title":"Qual Life Res"},{"issue":"2","key":"2332_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jval.2018.09.2842","volume":"22","author":"A Gnanasakthy","year":"2019","unstructured":"Gnanasakthy A, Barrett A, Evans E, D\u2019Alessio D, Romano CD. A review of patient-reported outcomes labeling for Oncology drugs approved by the FDA and the EMA (2012\u20132016). Value Health. 2019;22(2):203\u20139. https:\/\/doi.org\/10.1016\/j.jval.2018.09.2842.","journal-title":"Value Health"},{"issue":"7","key":"2332_CR38","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1158\/1078-0432.Ccr-15-2035","volume":"22","author":"PG Kluetz","year":"2016","unstructured":"Kluetz PG, Slagle A, Papadopoulos EJ, Johnson LL, Donoghue M, Kwitkowski VE, Chen WH, Sridhara R, Farrell AT, Keegan P, et al. Focusing on Core patient-reported outcomes in Cancer clinical trials: symptomatic adverse events, physical function, and Disease-related symptoms. Clin Cancer Res. 2016;22(7):1553\u20138. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-2035.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2332_CR39","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/01635581.2023.2170429","volume":"75","author":"I Migdanis","year":"2023","unstructured":"Migdanis I, Gioulbasanis I, Migdanis A, Armeni E, Sgantzos M, Kapsoritakis A, Kontogianni MD. Objective measurements of physical function to Predict Survival in patients with metastatic Cancer. Nutr Cancer. 2023;75(3):912\u201322. https:\/\/doi.org\/10.1080\/01635581.2023.2170429.","journal-title":"Nutr Cancer"},{"issue":"1","key":"2332_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00520-021-06394-4","volume":"30","author":"C Soucy","year":"2022","unstructured":"Soucy C, Bouchard DR, Hrubeniuk T, S\u00e9n\u00e9chal M. Variability in physical function for patients living with breast cancer during a 12-week exercise program. Support Care Cancer. 2022;30(1):69\u201376. https:\/\/doi.org\/10.1007\/s00520-021-06394-4.","journal-title":"Support Care Cancer"},{"key":"2332_CR41","doi-asserted-by":"publisher","unstructured":"Shehu E, Roggendorf S, Golla A, Koenig A, Stangl GI, Diestelhorst A, Medenwald D, Vordermark D, Steckelberg A, Schmidt H. Development and evaluation of a Multimodal supportive intervention for promoting physical function in older patients with Cancer. Cancers (Basel). 2022;14(11). https:\/\/doi.org\/10.3390\/cancers14112599.","DOI":"10.3390\/cancers14112599"},{"key":"2332_CR42","doi-asserted-by":"publisher","unstructured":"Brown LF, Kroenke K, Theobald DE, Wu J. Comparison of SF-36 vitality scale and fatigue Symptom Inventory in assessing cancer-related fatigue. Support Care Cancer. 2011;19(8):1255\u20139. https:\/\/doi.org\/10.1007\/s00520-011-1148-2.","DOI":"10.1007\/s00520-011-1148-2"},{"issue":"1","key":"2332_CR43","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.pec.2006.10.008","volume":"66","author":"JJ Griggs","year":"2007","unstructured":"Griggs JJ, Sorbero ME, Mallinger JB, Quinn M, Waterman M, Brooks B, Yirinec B, Shields CG. Vitality, mental health, and satisfaction with information after breast cancer. Patient Educ Couns. 2007;66(1):58\u201366. https:\/\/doi.org\/10.1016\/j.pec.2006.10.008.","journal-title":"Patient Educ Couns"},{"key":"2332_CR44","doi-asserted-by":"publisher","unstructured":"Pritlove C, Capone G, Kita H, Gladman S, Maganti M, Jones JM. Cooking for vitality: pilot study of an innovative Culinary Nutrition intervention for Cancer-related fatigue in Cancer survivors. Nutrients. 2020;12(9). https:\/\/doi.org\/10.3390\/nu12092760.","DOI":"10.3390\/nu12092760"},{"issue":"3","key":"2332_CR45","doi-asserted-by":"publisher","first-page":"e18325","DOI":"10.2196\/18325","volume":"5","author":"R Wolbers","year":"2021","unstructured":"Wolbers R, Bode C, Siemerink E, Siesling S, Pieterse M. Cognitive Bias Modification Training to Improve Implicit vitality in patients with breast Cancer: App Design using a Cocreation Approach. JMIR Form Res. 2021;5(3):e18325. https:\/\/doi.org\/10.2196\/18325.","journal-title":"JMIR Form Res"},{"issue":"2","key":"2332_CR46","first-page":"403","volume":"58","author":"EA Hahn","year":"2016","unstructured":"Hahn EA, Kallen MA, Jensen RE, Potosky AL, Moinpour CM, Ramirez M, Cella D, Teresi JA. Measuring social function in diverse cancer populations: evaluation of measurement equivalence of the patient reported outcomes Measurement Information System(\u00ae) (PROMIS(\u00ae)) ability to participate in Social Roles and activities short form. Psychol Test Assess Model. 2016;58(2):403\u201321.","journal-title":"Psychol Test Assess Model"},{"issue":"5","key":"2332_CR47","doi-asserted-by":"publisher","first-page":"432443","DOI":"10.1097\/00130404-200609000-00012","volume":"12","author":"CM Alfano","year":"2006","unstructured":"Alfano CM, Rowland JH. Recovery issues in cancer survivorship: a new challenge for supportive care. Cancer J. 2006;12(5):432443. https:\/\/doi.org\/10.1097\/00130404-200609000-00012.","journal-title":"Cancer J"},{"issue":"4","key":"2332_CR48","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/02841860701367878","volume":"46","author":"NM Aziz","year":"2007","unstructured":"Aziz NM. Cancer survivorship research: state of knowledge, challenges and opportunities. Acta Oncol. 2007;46(4):417\u201332. https:\/\/doi.org\/10.1080\/02841860701367878.","journal-title":"Acta Oncol"},{"issue":"12","key":"2332_CR49","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.4103\/jfmpc.jfmpc_1037_23","volume":"12","author":"S Muralidharan","year":"2023","unstructured":"Muralidharan S, Gore M, Katkuri S. Cancer care and economic burden-A narrative review. J Family Med Prim Care. 2023;12(12):3042\u20137. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1037_23.","journal-title":"J Family Med Prim Care"},{"key":"2332_CR50","doi-asserted-by":"publisher","unstructured":"Ding H, Mao A, Lin J, Wong MCS, Dong P, Qiu W. Using a Chinese time trade-off approach to explore the health utility level and quality of life of cancer patients in urban China: a multicentre cross-sectional study. Supportive care cancer: Official J Multinational Association Supportive Care Cancer. 2021;29(4):2215\u201323. https:\/\/doi.org\/10.1007\/s00520-020-05729-x.","DOI":"10.1007\/s00520-020-05729-x"},{"key":"2332_CR51","doi-asserted-by":"publisher","unstructured":"de Moor JS, Williams CP, Blinder VS. Cancer-Related Care costs and employment disruption: recommendations to reduce Patient Economic Burden as Part of Cancer Care Delivery. J Natl Cancer Inst Monogr. 2022;2022(59):79\u201384. https:\/\/doi.org\/10.1093\/jncimonographs\/lgac006.","DOI":"10.1093\/jncimonographs\/lgac006"},{"issue":"2","key":"2332_CR52","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11136-008-9307-8","volume":"17","author":"SH Park","year":"2008","unstructured":"Park SH, Cho MS, Kim YS, Hong J, Nam E, Park J, Cho EK, Shin DB, Lee JH, Lee WK. Self-reported health-related quality of life predicts survival for patients with advanced gastric cancer treated with first-line chemotherapy. Qual Life Res. 2008;17(2):207\u201314. https:\/\/doi.org\/10.1007\/s11136-008-9307-8.","journal-title":"Qual Life Res"},{"key":"2332_CR53","doi-asserted-by":"publisher","unstructured":"Srinath A, van Merode F, Rao SV, Pavlova M. Barriers to cervical cancer and breast cancer screening uptake in low- and middle-income countries: a systematic review. Health Policy Plan. 2023;38(4):509\u201327. https:\/\/doi.org\/10.1093\/heapol\/czac104.","DOI":"10.1093\/heapol\/czac104"},{"key":"2332_CR54","doi-asserted-by":"publisher","first-page":"101043","DOI":"10.1016\/j.lanwpc.2024.101043","volume":"44","author":"Z Wang","year":"2024","unstructured":"Wang Z, Xia Q, Meng P, Lu C, Yang H, Feng XL, Huang Y. Social determinants of health and cancer screening in China. Lancet Reg Health West Pac. 2024;44:101043. https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101043.","journal-title":"Lancet Reg Health West Pac"},{"key":"2332_CR55","doi-asserted-by":"publisher","unstructured":"Laryionava K, Pfeil TA, Dietrich M, Reiter-Theil S, Hiddemann W, Winkler EC. The second patient? Family members of cancer patients and their role in end-of-life decision making. BMC Palliat Care. 2018;17(1):29. https:\/\/doi.org\/10.1186\/s12904-018-0288-2.","DOI":"10.1186\/s12904-018-0288-2"},{"issue":"1","key":"2332_CR56","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1186\/s12885-019-6181-4","volume":"19","author":"CL Niedzwiedz","year":"2019","unstructured":"Niedzwiedz CL, Knifton L, Robb KA, Katikireddi SV, Smith DJ. Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority. BMC Cancer. 2019;19(1):943. https:\/\/doi.org\/10.1186\/s12885-019-6181-4.","journal-title":"BMC Cancer"},{"issue":"10","key":"2332_CR57","doi-asserted-by":"publisher","first-page":"e049259","DOI":"10.1136\/bmjopen-2021-049259","volume":"11","author":"ME Zettler","year":"2021","unstructured":"Zettler ME, Feinberg BA, Jeune-Smith Y, Gajra A. Impact of social determinants of health on cancer care: a survey of community oncologists. BMJ Open. 2021;11(10):e049259. https:\/\/doi.org\/10.1136\/bmjopen-2021-049259.","journal-title":"BMJ Open"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-025-02332-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12955-025-02332-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-025-02332-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T23:32:02Z","timestamp":1736638322000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-025-02332-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,12]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2332"],"URL":"https:\/\/doi.org\/10.1186\/s12955-025-02332-8","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,12]]},"assertion":[{"value":"22 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol of this study received approval from the Ethics Committee of Harbin Medical University (HMUIRB2023005).Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}